will insurance cover glp 1 for high blood pressure Medicare covers GLP-1s to treat diabetes and some other health conditions, including obstructive sleep apnea and cardiovascular disease, but not obesity Insurance coverage just changed for

World Health Organization

Between 2025 and 2030, the global pharmaceutical industry faces a Loss of Exclusivity (LOE) wave that puts an estimated $200 billion to $400 billion in branded drug revenue at direct risk.

These agents target multiple hormone pathways involved in appetite regulation, insulin secretion, energy expenditure, and hepatic metabolism

Eli Lillys first nine months of 2025 underscored the scale of the GLP-1 surge: Mounjaro and Zepbound generated $39.5 billion in revenue and surpasses Mercks Keytruda as the worlds best-selling medicine[5]

Break Down Heavy Meals and Prevent Digestive Discomfort

Explore next-gen weight loss drugs surpassing GLP-1, with new targets like amylin, ACSL5 & ActRII reshaping the obesity treatment landscape.